Research identifies protein that regulates creation of fat cells

Biological sciences major Adam Reese may have found the key to keep fat cells from forming.

The University of Delaware junior believes he has identified the trigger that turns a stem cell into a fat cell. Located on the surface of cells, the trigger — a protein called endoglin — regulates what type of cell an existing stem cell will become.

Working in the UD Department of Biological Sciences‘ laboratory of cellular signaling and dynamics with assistant professor Anja Nohe, Reese investigates ways to combat osteoporosis. His findings may also have implications for obesity.

Patients afflicted with osteoporosis lose bone mass as they age. Bone is a dynamic tissue, constantly renewed by removal or reabsorption of old bone and formation of new bone. Through this cellular remodeling process, roughly one-fifth of an adult’s skeleton is replaced each year. Of the limited treatments developed to reduce bone loss, most have potentially serious side effects, are cost prohibitive, or are difficult to use.

Reese, with the help of graduate student Joyita Dutta, found that the amount of endoglin on a cell’s surface indicates whether the cell will become a fat cell or a bone cell.

“What would happen if you could make the cell stop making the protein?” Reese said. “You could affect whether or not it’s even a fat cell.”

If the amount of endoglin on the cell surface could be decreased, the amount of cells turning into bone would rise, leading to an increase in bone strength, thus ending osteoporosis.

Continue reading

Incoming search terms:

tong yuan stem cell, Rongxiang Xu wiki.

Stem Cells Could Halt Osteoporosis and Promote Bone Growth

McGill University
Image via Wikipedia

While interferon gamma sounds like an outer space weapon, it’s actually a hormone produced by our own bodies, and it holds great promise to repair bones affected by osteoporosis. In a new study published in the journal Stem Cells, researchers from the Research Institute of the McGill University Health Centre explain that tweaking a certain group of multipotent stem cells (called mesenchymal stem cells) with interferon (IFN) gamma may promote bone growth.

“We have identified a new pathway, centered on IFN gamma, that controls the bone remodelling process both in-vivo and in-vitro,” explains Dr. Kremer, the study’s lead author and co-director of the Musculoskeletal Axis of the McGill University Health Centre. “More studies are required to describe it more precisely, but we are hopeful that it could lead to a better understanding of the underlying causes of osteoporosis, as well as to innovative treatments.”

Continue reading

Incoming search terms:

can ips cells cure osteoporosis, ips cells osteoporosis, Osteoporosis and stem cell therapy.